Sputum culture is generally considered a low-value microbiology test, due to limited sensitivity and specificity in identifying bacterial pathogens. An analysis of 3,200 samples processed at Pathlab between July 2023 and June 2024 found that only 6 per cent grew a respiratory pathogen resistant to amoxycillin, and just 0.7 per cent grew a pathogen resistant to doxycycline (excluding Pseudomonas). In the majority of cases, results did not change patient management.
Despite this, the volume of sputum samples being processed has increased in recent years.
Sputum culture in the community setting is only indicated in the following circumstances:
To ensure appropriate testing, Pathlab may decline requests for sputum culture in patients that do not fall into the above categories.
Read more on the Pathlab website.
This week the Pinnacle Incorporated Executive Committee has written to Dr Ashley Bloomfield, Director-General of Health and Labour MPs across the Midland region asking them to reconsider lowering the screening age for Māori and Pacific people.
Read morePathlab is changing its coeliac disease testing algorithm and will no longer perform upfront total IgA testing on all coeliac requests. From 11 November 2025, total IgA will only be added when results suggest possible IgA deficiency, with anti-DGP IgG continuing to be added automatically when IgA is <0.05 g/L. This updated approach aligns with published evidence and current practice at Canterbury Health Laboratories.
Read moreThe B4 School Check (B4SC) is a universal, comprehensive check for all four-year-old’s that includes height and weight, vision and hearing, immunisations, oral health, and behavioral and developmental components.
View detailsNational Cervical Screening Programme screening updates.